Comparison of motor activity and sleep in patients with complex partial seizures on levetiracetam treatment and a group of healthy subjects

Behavioural Neurology

Volumn 18, Issue 3, 2007, Pages 165-170

  Yilmaz, Hikmet ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Actimeter; Drowsiness; Levetiracetam; Nap episodes; Sleep efficiency; Total activity score

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; HYDANTOIN; OXCARBAZEPINE; VALPROIC ACID;

ACTIMETRY; ADD ON THERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG EFFECT; EPWORTH SLEEPINESS SCALE; FEMALE; FOCAL EPILEPSY; HOSPITAL PERSONNEL; HUMAN; MALE; MONOTHERAPY; MOTOR ACTIVITY; NURSE; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SLEEP; SLEEP PARAMETERS; SLEEP TIME; SLEEP WAKING CYCLE; SOMNOLENCE; TREATMENT DURATION; WAKEFULNESS;

EID: 34548102149     PISSN: 09534180     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/832769     Document Type: Article

References (21)

1. C.V. Bazil, Epilepsy and sleep disturbance, Epilepsy Behav 4 (2003), 39-45.
2. C. Bell, H. Vanderlinden and R. Hiersemenzel, The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy, J Sleep Res 11 (2002), 255-263.
3. P. Boon, P. Chauvel, B. Pohlmann-Eden, C. Otoul and S. Wroe, Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy, Epilepsy Res 48 (2002), 1424-1425.
4. D.E. Briggs and J.A. French, Levetiracetam safety profiles and tolerability in epilepsy patients, Expert Opin Drug Saf 3 (2004), 415-424.
5. A. Brooks and L. Lack, A brief afternoon nap following nocturnal sleep restriction: which nap duration is most recuperative? Sleep 29 (2006), 831-840.
6. A. Cicolin, U. Magliola, A. Giordano, A. Terreni, C. Buca and R. Mutani, Effects of Levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers, Epilepsia 47 (2006), 82-85.
7. J.P. Cravero and G.T. Blike, Pediatric sedation, Curr Opin Anaesthesiol 17(3) (2004), 247-251.
8. M. Hamilton, A rating scale for depression, J Neurol Neurosurg Psychiatry 23 (1960), 56-62.
9. R. Khatami, A.M. Siegel and C.L. Bassetti, Hypersomnia in an epilepsy patient treated with levetiracetam, Epilepsia 46 (2005), 588-589.
10. R. Khatami, D. Zutter, A.M. Siegel, j. Mathis, F. Donati and C.L. Bassetti, Sleep-wake habits and disorders in a series of 100 adult epilepsy patients - a prospective study, Sleep 15 (2006), 299-306.
11. M. Littner, C. Kushida, M. Wise, D.G. Davila, T. Morgenthaler, T. Lee-Chiong, M. Hirshkowitz, L.L. Daniel, D. Bailey, R.B. Berry, S. Kapen and M. Kramer, Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test, Sleep 28 (2005), 113-121.
12. S. Malviya, T. Voepel-Lewis, R.J. Ramamurthi, C Burke and A.R. Tait, Clonidine for the prevention of emergence agitation in young children: efficacy and recovery profile, Paediatr Anaesth 16(5) (2006), 554-559.
13. P.N. Patsalos, Pharmacokinetic profile of levetiracetam: toward ideal characteristics, Pharmacol Ther 85 (2000), 77-85.
14. E. Perruca, Clinical pharmacology and therapeutic use of the new antiepileptic drugs, Fundam Clin Pharmacol 15 (2001), 405-417.
15. A. Rechtschaffen and A. Kales, A Manual of Standardized Terminology: Techniques and Scoring System for Sleep Stages in Human Subjects, UCLA Brain Information Service/Brain Research Institute, Los Angeles, 1968.
16. A. Sadeh, P.J. Hauri, D.F. Kripke and P. Lavie, The role of actigraphy in the evaluation of sleep disorders, Sleep 18 (1995), 288-302.
17. A. Sadek and J.A. French, Levetiracetam, in: The Treatment of Epilepsy, S. Shorvon, E. Perucca, D. Fish et al., eds, Blackwell Science, Malden, 2004.
18. J.M. Slinkard, Multiple sleep latency test and maintenance of wakefulness test, Respir Care Clin N Am 12 (2006), 17-22.
19. C. Smyth, The Pittsburgh Sleep Quality Index (PSQI), Insight 25 (2000), 97-98.
20. Y.H. Sohn, A. Kaelin-Lang, H.Y. Jung and M. Hallet, Effect of levetiracetam on human corticospinal exitability, Neurology 57 (2001), 858-863.
21. T.E. Welty, B.E. Gidal, D.M. Ficker and M.D. Privitera, Levetiracetam: a different approach to the pharmacotherapy of epilepsy, Ann Pharmacother 36 (2002), 296-304.